Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button


DHgate

Home > Press > Starpharma advances agrochemical program with improved performance of major product

Abstract:
· Starpharma's Priostar® dendrimer found to improve the effectiveness of agrochemicals including glyphosate, the most commonly used herbicide globally
· Starpharma's internal development program is focused on the improvement of several existing agrochemicals
· New patent filing to extend coverage to 2029

Starpharma advances agrochemical program with improved performance of major product

Melbourne, Australia | Posted on July 11th, 2011

Starpharma Holdings Limited (ASX:SPL, OTCQX:SPHRY) today announced encouraging results from studies applying its Priostar® dendrimer technology to the improvement of globally significant agrochemicals.

Starpharma's studies have demonstrated a number of improvements in these preliminary studies including the ability to increase the effectiveness of agrochemicals such as glyphosate, the most commonly used herbicide globally (also known by the trade name Roundup®) with annual sales in excess of US$5bn.

In the past year Starpharma's internal agrochemical program has explored a number of key off-patent agrochemical agents in combination with the company's proprietary dendrimer technology. In addition to glyphosate, these include the major insecticide imidacloprid (annual sales of US$1bn) and the herbicide trifluralin (annual sales of US$300m)1..

"We are very pleased to report the company's progress in the agrochemical program. The selection of commercially-significant lead candidates by Starpharma gives us a clear focus for future work." said Starpharma CEO Dr Jackie Fairley.

Based on initial studies, Starpharma's Priostar® dendrimers are well placed to capture several opportunities in the US$40bn global agrochemical sector as the market continues to seek new technologies to improve efficiency and enhance performance.

Key results arising from the studies found that Starpharma's Priostar® dendrimers offered benefits including:

· solubility enhancement for more concentrated formulations;
· improved herbicidal activity as measured by brownout; and
· modification of soil penetration properties.

As illustrated below, the addition of Starpharma's patented dendrimers to the glyphosate solution showed an increase in the brownout, or rate of vegetation dying off. This suggests that the dendrimer was significantly increasing the activity of the glyphosate.

Fertilisers and agrochemicals - and their application - represent a significant cost for farmers. More effective chemical formulations could reduce the expense of a crop treatment cycle and the need for reapplication, potentially improving the environmental profile of such products.

These trends are reflected in the United Nations Food and Agriculture Organization's report "World agriculture: towards 2030/2050" which determined that much of future food production growth will come from higher productivity. The report also identifies the promise of biotechnology as a means of achieving this goal.

"Starpharma's internal agrochemicals program focuses on reformulating known generic agents with its proprietary dendrimers to improve their performance. This offers the potential for reduced frequency and amount of application, with the potential to reduce the chemicals' environmental impact." Dr Fairley concluded.

Key patents have already been allowed or granted by the US and other patent offices for broad protection of Priostar® dendrimer technology, relevant to both agrochemical and industrial applications. Additionally Starpharma has filed for protection for specific agrochemical applications, which if granted would provide patent coverage to 2029.

Starpharma's agrochemicals program has been assisted by funding under the Victorian Government's STIUP program announced in March 2011. Starpharma also has partnered programs with a growing number of leading agrochemical companies.

####

For more information, please click here

Copyright © Starpharma Holdings Limited

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Electric-car battery materials could harm key soil bacteria February 11th, 2016

Creating a color printer that uses a colorless, non-toxic ink inspired by nature February 11th, 2016

SLAC X-ray laser turns crystal imperfections into better images of important biomolecules: New method could remove major obstacles to studying structures of complex biological machines February 11th, 2016

Nanoparticle reduces targeted cancer drug's toxicity February 11th, 2016

Announcements

Research reveals carbon films can give microchips energy storage capability: International team from Drexel University and Paul Sabatier University reveals versatility of carbon films February 11th, 2016

Creating a color printer that uses a colorless, non-toxic ink inspired by nature February 11th, 2016

SLAC X-ray laser turns crystal imperfections into better images of important biomolecules: New method could remove major obstacles to studying structures of complex biological machines February 11th, 2016

Nanoparticle reduces targeted cancer drug's toxicity February 11th, 2016

Patents/IP/Tech Transfer/Licensing

New thin film transistor may lead to flexible devices: Researchers engineer an electronics first, opening door to flexible electronics February 10th, 2016

Joint Efforts by Iranian, Malaysian Scientists Produce Antibacterial Coatings for Isolated Areas February 4th, 2016

Silicon-based metamaterials could bring photonic circuits February 1st, 2016

Therapeutic Solutions International Licenses Dexosome Clinical Stage Cancer Immunotherapy Product From Gustave Roussy European Cancer Centre: FDA Cleared Immuno-Oncology Technology to Resume Clinical Development for Solid Tumor Patients January 27th, 2016

Food/Agriculture/Supplements

Scientists have put a high precision blood assay into a simple test strip: Researchers have developed a new biosensor test system based on magnetic nanoparticles February 3rd, 2016

Herbal Extracts Applied to Synthesize Titanium Dioxide Nanoparticles January 28th, 2016

Antibacterial Nanocomposites Designed in Iran for Foodstuff Packaging January 20th, 2016

HSI 2016 | Hyperspectral Imaging and Applications conference is announced January 13th, 2016

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







Car Brands
Buy website traffic